E-LIB Suche - Ergebnisse für: Wang, Shining

1

A phase Ib study evaluating the recommended phase II dose, ..:

Juric, Dejan ; Barve, Minal ; Vaishampayan, Ulka...
Cancer Medicine. 13 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

2

Origin and stability of pit lake water in Baiyinhua, Inner ..:

Pei, Shengliang ; Zhang, Deqiang ; Wang, Shining.
Isotopes in Environmental and Health Studies. , 2024

Link: https://doi.org/10.1080/..

3

A Multi-Scale Graph Based on Spatio-Temporal-Radiometric In..:

Zhang, Peijing ; Jiang, Jinbao ; Kou, Peng..
Remote Sensing. 16 (2024) 3 - p. 560 , 2024

Link: https://doi.org/10.3390/..

4

P-203 Rationale and design of three ongoing phase 1/2 trial..:

Mian, Hira ; Touzeau, Cyrille ; Holstein, Sarah...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S147 , 2023

Link: https://doi.org/10.1016/..

5

Iron pools of the typical loess–palaeosol sequence and thei..:

Sun, Zhong‐Xiu ; Wang, Shi‐Ning ; Jiang, Ying‐Ying..
Earth Surface Processes and Landforms. 49 (2023) 2 - p. 511-524 , 2023

Link: https://doi.org/10.1002/..

6

A phase I, first-in-human study of TAK-164, an antibody–dru..:

Kim, Richard ; Leal, Alexis D. ; Parikh, Aparna...
Cancer Chemotherapy and Pharmacology. 91 (2023) 4 - p. 291-300 , 2023

Link: https://doi.org/10.1007/..

7

PB2129: THE MODAKAFUSP ALFA IINNOVATE CLINICAL DEVELOPMENT ..:

Holstein, Sarah A. ; Mian, Hira ; Touzeau, Cyrille...
HemaSphere. 7 (2023) S3 - p. e9860835 , 2023

Link: https://doi.org/10.1097/..

8

The correlation between Th17/Treg immune dysregulation and ..:

Yang, Xiaojing ; Chen, Leigang ; Wang, Shining...
Immunity, Inflammation and Disease. 11 (2023) 7 - p. , 2023

Link: https://doi.org/10.1002/..

9

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibitio..:

Gordon, Leo I. ; Karmali, Reem ; Kaplan, Jason B....
Oncotarget. 14 (2023) 1 - p. 57-70 , 2023

Link: https://doi.org/10.18632..

10

Advances in photo-catalytic oxidation of NH3 over modified ..:

Jiang, Jiaying ; Gao, Fengyu ; Wang, Shining...
Journal of Environmental Chemical Engineering. 11 (2023) 5 - p. 110602 , 2023

Link: https://doi.org/10.1016/..

11

Correction to: A phase I, first-in-human study of TAK-164, ..:

Kim, Richard ; Leal, Alexis D. ; Parikh, Aparna...
Cancer Chemotherapy and Pharmacology. 91 (2023) 4 - p. 301-301 , 2023

Link: https://doi.org/10.1007/..

12

Adapt-Kcr: a novel deep learning framework for accurate pre..:

Li, Zutan ; Fang, Jingya ; Wang, Shining...
Briefings in Bioinformatics. 23 (2022) 2 - p. , 2022

Link: https://doi.org/10.1093/..

13

A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 ..:

Pratz, Keith W. ; Kaplan, Jason ; Levy, Moshe...
Haematologica. , 2022

Link: https://doi.org/10.3324/..

14

Population pharmacokinetic and exposure‐response analyses f..:

Gupta, Neeraj ; Reckamp, Karen L. ; Camidge, David R....
Clinical and Translational Science. 15 (2022) 5 - p. 1143-1154 , 2022

Link: https://doi.org/10.1111/..

15

Pharmacokinetics, pharmacodynamics and safety assessment of..:

Wang, Shining ; Chen, Grace ; Merlo Pich, Emilio...
British Journal of Clinical Pharmacology. 88 (2022) 6 - p. 2899-2908 , 2022

Link: https://doi.org/10.1111/..